Literature DB >> 30967629

PARI (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells.

Claudia M Nicolae1, Michael J O'Connor1, Emily M Schleicher1, Chunhua Song2, Raghavendra Gowda3, Gavin Robertson3, Sinisa Dovat2, George-Lucian Moldovan4.   

Abstract

Hyperproliferative cancer cells face increased replication stress, which can result in accumulation of DNA damage. As DNA damage can arrest proliferation, and, in the case of myeloid leukemia, induce differentiation of cancer cells, understanding the mechanisms that regulate the replication stress response is paramount. Here, we show that PARI, a replisome protein involved in regulating DNA repair and replication stress, suppresses differentiation of myeloid leukemia cells. We show that PARI is overexpressed in myeloid leukemia cells, and its knockdown reduces leukemia cell proliferation in vitro and in vivo in xenograft mouse models. PARI depletion enhances replication stress and DNA-damage accumulation, coupled with increased myeloid differentiation. Mechanistically, we show that PARI inhibits activation of the NF-κB pathway, which can initiate p21-mediated differentiation and proliferation arrest. Finally, we show that PARI expression negatively correlates with expression of differentiation markers in clinical myeloid leukemia samples, suggesting that targeting PARI may restore differentiation ability of leukemia cells and antagonize their proliferation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30967629     DOI: 10.1038/s41388-019-0810-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48.

Authors:  Lothar Vassen; Ulrich Dührsen; Christian Kosan; Hui Zeng; Tarik Möröy
Journal:  Am J Blood Res       Date:  2012-11-25
  2 in total
  6 in total

1.  Characterization of alternative splicing events and prognostic signatures in breast cancer.

Authors:  Pihua Han; Jingjun Zhu; Guang Feng; Zizhang Wang; Yanni Ding
Journal:  BMC Cancer       Date:  2021-05-22       Impact factor: 4.430

2.  The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.

Authors:  Ayesha A Shafi; Chris M McNair; Jennifer J McCann; Mohammed Alshalalfa; Anton Shostak; Tesa M Severson; Yanyun Zhu; Andre Bergman; Nicolas Gordon; Amy C Mandigo; Saswati N Chand; Peter Gallagher; Emanuela Dylgjeri; Talya S Laufer; Irina A Vasilevskaya; Matthew J Schiewer; Michael Brunner; Felix Y Feng; Wilbert Zwart; Karen E Knudsen
Journal:  Nat Commun       Date:  2021-01-15       Impact factor: 14.919

3.  PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer.

Authors:  Bo Chen; Jianguo Lai; Danian Dai; Rong Chen; Ning Liao; Guanfeng Gao; Hailin Tang
Journal:  Ther Adv Med Oncol       Date:  2020-11-24       Impact factor: 8.168

4.  Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines.

Authors:  Federica Riccio; Elisa Micarelli; Riccardo Secci; Giulio Giuliani; Simone Vumbaca; Giorgia Massacci; Luisa Castagnoli; Claudia Fuoco; Gianni Cesareni
Journal:  Cell Death Discov       Date:  2022-01-10

5.  ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.

Authors:  Shikshya Shrestha; Anthony Lamattina; Gustavo Pacheco-Rodriguez; Julie Ng; Xiaoli Liu; Abhijeet Sonawane; Jewel Imani; Weiliang Qiu; Kosmas Kosmas; Pierce Louis; Anne Hentschel; Wendy K Steagall; Rieko Onishi; Helen Christou; Elizabeth P Henske; Kimberly Glass; Mark A Perrella; Joel Moss; Kelan Tantisira; Souheil El-Chemaly
Journal:  Life Sci Alliance       Date:  2022-02-18

6.  Depletion of C12orf48 inhibits gastric cancer growth and metastasis via up-regulating Poly r(C)-Binding Protein (PCBP) 1.

Authors:  Lele Lin; Hongbo Li; Dike Shi; Zhiqiang Liu; Yunhai Wei; Wei Wang; Dan Wu; Baozhong Li; Qingqu Guo
Journal:  BMC Cancer       Date:  2022-01-31       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.